FDA Drug Application (022222) for ULTRESA by FOREST LABS INC

Back to FDA Applications sponsored by FOREST LABS INC

Application Number022222
Product Number001
FormCAPSULE, DELAYED RELEASE;ORAL
Dosage27,600USP UNITS;13,800USP UNITS;27,600USP UNITS
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameULTRESA
Active IngredientPANCRELIPASE (AMYLASE;LIPASE;PROTEASE)

Active IngredientCount
List of drugs with Active Ingredient AMYLASE7
List of drugs with Active Ingredient LIPASE7
List of drugs with Active Ingredient PANCRELIPASE7
List of drugs with Active Ingredient PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)7
List of drugs with Active Ingredient PROTEASE7


Back to FDA Applications sponsored by FOREST LABS INC